Advertisement
Advertisement
Trending on Urology Times
1
European Commission approves subcutaneous pembrolizumab
2
FDA grants 510(k) clearance to new edition of Focal One robotic HIFU
3
Kim Nguyen Chi, MD, highlights patient-reported outcome data from AMPLITUDE
4
FDA greenlights pivotal trial of gene-editing therapy for PH1
5
